Connect with us

News

Dr. Reddy’s to Release Q3 FY 20 results on January 27, 2020  Earnings Call Slated for January 27, 2020 @ 6:30 PM IST / 8:00 AM EST

gbafNews28

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the third quarter ended December 31, 2019 on Monday, January 27, 2020 after the Board Meeting.

Summary of Events

Event

Date and Time

Medium

Release of financial results

January 27th, after the Board Meeting

Stock Exchange, Media, Company website, Business wire, Email

Press meet presentation

Will be available on the Companys website

Companys website www.drreddys.com

Earnings Call

January 27th, 6:30 PM IST / 8:00 AM EST

Hosted by the Company

(Details below)

Playback of Earnings Call

After the earnings call till February 3rd, 2020

Details below

Transcript of the Earnings call

Will be available on the Companys website

URL available on Companys website, www.drreddys.com

Earnings Call Following the release, the management of the Company will host an earnings call to discuss the Companys financial performance. (Dial In and other details given below)

Play Back The play back will be available after the earnings call, till February 3rd, 2020. For play back dial in phone No: 022 7194 5757 / 022 6663 5757, and Playback Code is 58113.

 Conference Dial-In Numbers

Universal Access Number:

 

+91 22 6280 1219

+91 22 7115 8120

Local Access Number:

Available all over India

+91 70456 71221

International Toll Free Number:

USA:1 866 746 2133

UK: 0 808 101 1573

Singapore: 800 101 2045

Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the above numbers. The operator will provide instructions on asking questions before and during the call.

About Dr. Reddys: Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products “ Dr. Reddys offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddys operates in markets across the globe. Our Major markets include “ USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the managements current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may”, “will”, “should”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization , including related integration issues.

The company assumes no obligation to update any information contained herein.

INVESTOR RELATIONS

AMIT AGARWAL

[email protected]

(Ph: +91-40-49002135)

MEDIA RELATIONS

MITALI SARKAR

[email protected]

(Ph: +91-40-49002121)

News

Eden Ranks #14 on San Francisco Business Times’ Fastest Growing Private Companies in the Bay Area List

gbafNews28

Edenthe all-in-one workplace management platform that empowers clients to work wonderstoday announced it has been ranked #14 on San Francisco Business Times 2020 Fastest Growing Private Companies in the Bay Area. The annual list is an exclusive ranking of the regions fastest-growing private companies across software, fintech, construction, healthcare, professional services & manufacturing, representing one of the most important segments of the local economy. The winners and rankings were unveiled at a virtual awards gala on October 29, 2020.

Were honored to be among this years group of innovative, high-growth companies highlighted by San Francisco Business Times, said Joe Du Bey, CEO and Co-Founder of Eden. This recognition is a result of our talented, hardworking and passionate team who is focused on creating a better place to work, for everyone, through our suite of software products. Were at a crucial moment in reimagining the future of work and our software is aimed at creating not only a more efficient workplace but a safe one, ensuring our clients re-enter with confidence.

Companies on the list are ranked by percent growth in revenue from 2017 to 2019. Those on this years list logged astounding growth, the top 100 added 6,000 jobs, while 43 companies grew by 100% or more and nine saw revenue skyrocket 500% or higher. In order to be considered, the companies must also have had at least $200,000 in revenue in 2016 and must be privately held and headquartered in counties covered by SF Business Times – San Francisco, Alameda, San Mateo, Contra Costa and Marin.

Edens Workplace Management Software-as-a-Service (SaaS) toolsincluding COVID Team Safety, visitor management, modern ticketing, room booking, facilities management software, as well as facilities services marketplaceenable innovative companies from BarkBox, to Knotel, to Terminal and more to better run their workplace(s), ensuring they have the best possible experience for their employees and visitors. Founded in 2015 and available globally, Eden offers all the necessary software to run a high-standards office in one comprehensive easy-to-use, cost-effective platform on flexible terms.

About Eden: Eden is the all-in-one workplace management platform that makes it easier for companies to run their offices. Edens best-in-class Software-as-a-Service (SaaS) suite helps teams safely return to the office with the newly-released COVID Team Safety app, register visitors, seamlessly track employee ticketing and helpdesk requests, book rooms and manage their maintenance. Eden is based in San Francisco and investors include Y Combinator, Bessemer Venture Partners, Fifth Wall, S28 Capital, Reshape and JLL. Edens mission is to create a better place to work, for everyone. To learn more, visit www.eden.io.

Media Contact:

Elise Szwajkowski

Account Supervisor, Marino PR

[email protected]

(212) 402-3495

Continue Reading

News

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

gbafNews28

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Fennec Pharmaceuticals Inc. (Fennec or the Company) (NASDAQ: FENC) securities between February 11, 2020 and August 10, 2020, inclusive (the Class Period).

If you are a shareholder who suffered a loss, click here to participate.

On August 11, 2020, before the market opened, Fennec disclosed that it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Companys New Drug Application (NDA) for PEDMARK. According to the CRL, after recent completion of a pre-approval inspection of the manufacturing facility of [Fennecs] drug product manufacturer, the FDA identified deficiencies resulting in a Form 483, which is a list of conditions or practices that are required to be resolved prior to the approval of PEDMARK.

On this news, the Companys share price fell $3.51, or 34%, to close at $6.66 per share on August 11, 2020, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the manufacturing facilities for PEDMARK, the Companys sole product candidate, did not comply with current good manufacturing practices; (2) that, as a result, regulatory approval for PEDMARK was reasonably likely to be delayed; and (3) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased or otherwise acquired Fennec securities during the Class Period, you may move the Court no later than November 2, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

[email protected]

www.frankcruzlaw.com

Continue Reading

News

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portland General Electric Company (POR)

gbafNews28

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Portland General Electric Company (PGE or the Company) (NYSE: POR) securities between April 24, 2020 and August 24, 2020, inclusive (the Class Period).

If you are a shareholder who suffered a loss, click here to participate.

On August 24, 2020, after the market closed, PGE announced that it had incurred losses of $127 million as of August 24, 2020. PGE further stated that personnel entered into a number of energy trades during 2020, with increasing volume accumulating late in the second quarter and into the third quarter, resulting in significant exposure to the Company. In addition, the Company announced that it had formed a Special Committee to review the energy trading that led to the losses and the Companys procedures and controls related to the trading.

On this news, the Companys share price fell $3.51, or nearly 8%, to close at $38.45 per share on August 24, 2020, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that PGE lacked effective internal controls over its energy trading practices; (2) that PGE personnel had entered energy trades during 2020, with increasing volume accumulating late in the second quarter and into the third quarter, that created significant negative financial exposure for PGE; (3) that, as a result, the Company was reasonably likely to incur significant losses; and (4) that, as a result of the foregoing, Defendants positive statements about the Companys business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased or otherwise acquired PGE securities during the Class Period, you may move the Court no later than November 2, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

[email protected]

www.frankcruzlaw.com

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News57 mins ago

Eden Ranks #14 on San Francisco Business Times’ Fastest Growing Private Companies in the Bay Area List

Edenthe all-in-one workplace management platform that empowers clients to work wonderstoday announced it has been ranked #14 on San Francisco...

gbafNews28 gbafNews28
News57 mins ago

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against HDFC Bank Limited (HDB)

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead...

gbafNews28 gbafNews28
News57 mins ago

Pioneer Floating Rate Trust Required Notice to Shareholders Sources of Distribution Under Section 19(a)

Pioneer Floating Rate Trust (NYSE: PHD) today reported sources of distribution for October and this fiscal year to date.  ...

gbafNews28 gbafNews28
News57 mins ago

COVID-19: Global Air Ambulance Market 2020-2024 | Increasing Prevalence of Infectious Diseases to Boost Market Growth | Technavio

Technavio has been monitoring the air ambulance market and it is poised to grow by USD 4.27 billion during 2020-2024,...

gbafNews28 gbafNews28
News57 mins ago

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portland General Electric Company (POR)

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead...

gbafNews28 gbafNews28
News57 mins ago

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 2, 2020 deadline to file a lead...

gbafNews28 gbafNews28
News1 hour ago

Bitglass Named a Leader in Gartner’s Magic Quadrant for CASBs for Third Consecutive Year

Bitglass, the Total Cloud Security Company, announced today that it has been named a Leader in the 2020 Gartner Magic...

gbafNews28 gbafNews28
News1 hour ago

Daimler Trucks and Torc Partner With Luminar to Enable Automated Trucking – Daimler Trucks Acquires Minority Stake in Luminar

Today, Luminar Technologies, Inc., the global leader in automotive lidar hardware and software technology, and the worlds largest commercial vehicle...

gbafNews28 gbafNews28
News1 hour ago

Amazon Announces First Fulfillment Center in North Dakota

(NASDAQ: AMZN) “ Amazon.com, Inc. plans to open its first fulfillment center in the state of North Dakota in Fargo....

gbafNews28 gbafNews28
News1 hour ago

COVID-19 Impact & Recovery Analysis – Salt Market 2020-2024 | Wide Range of Industrial Applications to Boost Growth | Technavio

The salt market is expected to grow by 33.57 million MT during 2020-2024, according to Technavio. The report offers a...